Dizaltan Tablet 5/100 mg
Amlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.
MFDS item code 201502698 · Approved 2015.04.30
This product's status changed to Approval withdrawn on 2024.03.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension; initial treatment of Stage II hypertension
This medication is used to effectively lower blood pressure in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of amlodipine or losartan. It is also utilized as initial therapy in patients with stage 2 hypertension who require combination therapy to reach target blood pressure. This medication helps manage hypertension and is useful in reducing the risk of cardiovascular diseases. Therefore, this medication is used to improve blood pressure control.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. For patients taking amlodipine and losartan concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 milligrams once daily. ○ Patients with renal impairment: No dose adjustment is required in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients being treated with high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ○ Older patients: For older patients aged 75 years or older, a starting dose of losartan of 25 milligrams once daily is recommended; therefore, administration of this medicine as initial therapy is not recommended.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, administration of this medicine is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be stopped immediately upon confirmation of pregnancy. Decreased amniotic fluid may occur due to fetal kidney dysfunction, which increases the risk of fetal growth retardation or malformations. Risks to the fetus should be adequately recognized even when taking this medication during early pregnancy, and if unavoidable, it should be administered under strict supervision by a specialist. Patients with reduced intravascular blood volume, such as those taking diuretics, may have a risk of hypotension, and their condition should be stabilized before administering this medication. This medication should not be given to patients with allergies to the active ingredients or similar components, pregnant or breastfeeding women, patients with severe liver dysfunction, severe aortic stenosis, and those in a state of shock. Due to the blood pressure-lowering effect, dizziness or drowsiness may occur, so caution should be taken when driving or operating hazardous machines. During treatment with this medication, regular monitoring of blood pressure, renal function, and potassium levels is required to check for abnormalities. Caution is needed when taking this medication with other antihypertensives, potassium-sparing diuretics, or potassium supplements, as potassium levels may increase. This medication is not recommended for children under 18 years of age as safety and efficacy have not been established. In elderly patients, especially those 75 years of age or older, initial dose adjustment is necessary, and consultation with a specialist is advised as the dosage may not be suitable. In case of overdose, severe hypotension and cardiac arrhythmias may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be kept out of reach of children, and transferring it to another container could lead to quality degradation or accidents.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature.
Light pink rectangular film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Seoul Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Huwons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.